RATINGEN, Germany, Jan. 23, 2023 (GLOBE NEWSWIRE) — Fujifilm Europe has announced its partnership with World Cancer Day, an initiative led by the Union for International Cancer Control (UICC), the largest and oldest international cancer organization dedicated to . leaders in networking, building capacity and supporting initiatives that unite the cancer community to reduce the global burden of cancer, promote equity, and integrate cancer control into global health and development systems.
The day is done in 4 hoursth of February every year, and aims to raise awareness and improve education about cancer, as well as encourage governments to take action against the disease.
This year’s theme is ‘closing the care gap’, and focuses on the lack of access to health services that many people in the world face. Half of the world’s population does not have access to essential health services. When it comes to cancer, many people do not accept primary care, even though we live in a time of tremendous progress in cancer prevention, diagnosis and treatment.
Fujifilm is committed to achieving universal health coverage, ensuring that everyone has access to essential health services. This applies not only to regions with developing health infrastructure, but also to developed countries. To achieve this, Fujifilm devices have long supported medical professionals in fast and accurate diagnosis. The company develops new tools, improves its technology and uses advanced AI algorithms to make research easier around the world.
These solutions extend to cancer prevention, research and analysis, as they help detect disease at an early stage. Toshihisa Iida, President and CEO at FUJIFILM Europe GmbH, said: “We are very proud to be a partner of World Cancer Day, and to show our dedication to advancing the fight against cancer. We believe that access to health care should be equal for all, and this can only be achieved by removing regional and economic barriers that prevent new innovations from reaching more patients. Although this is a difficult task , there is progress, we will continue to support initiatives like this to work towards our vision for a better health world.”
Dr Cary Adams, president of the Union for International Cancer Control
“As individuals, as a community, we can and must come together and break down barriers. We have achieved so much in the last decade in cancer care and control around the world but not talking about injustice in society is slowing down our progress. Closing the care gap is about fairness, dignity and basic rights to give everyone a chance to live longer and in better health.”
Read more about Fujifilm here fujifilm.com/uk/en/neverstop/worldcancerday
Information about FUJIFILM Europe GmbH
Fujifilm operates more than 50 companies and branches in Europe and employs more than 6000 people working in R & D, production, sales and service, at FUJIFILM Europe GmbH, located in Ratingen, Germany, and – act as the headquarters for the region. Throughout Europe, Fujifilm companies serve a variety of industries including medical technology, biopharmaceuticals, electronics, industrial products, chemicals, imaging systems, optics, data storage and all aspects of photography. For the past 20 years, the company has focused on health care – from research to prevention and treatment. Today, Fujifilm in Europe provides all types of patient care, in addition to the research, development and production of CDMO and advanced therapeutics, cell therapy and immunotherapy, as well as providing cell culture media and revolutionary drug solutions. change.
For more information, please visit: fujifilm.com
About World Cancer Day
World Cancer Day on 4 February is a global solidarity initiative led by the Union for International Cancer Control (UICC) to raise awareness and promote education about the disease, while calling for governments and individuals around the world.
Corporate Communications Director – Europe
FUJIFILM Europe GmbH
Deputy Director of Communications – Europe
FUJIFILM Europe GmbH
Photos accompanying this announcement are available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a3984b37-4f77-487b-a13d-89d77cd06530